Impact of interrupting antiretroviral therapy started during primary HIV-1 infection on plasma neurofilament light chain protein, a marker of neuronal injury: The SPARTAC trial
Alagaratnam J., Stöhr W., Hamlyn E., Porter K., Toombs J., Heslegrave A., Zetterberg H., Gisslén M., Underwood J., Schechter M., Kaleebu P., Tambussi G., Kinloch S., Miro JM., Kelleher AD., Babiker A., Frater J., Winston A., Fidler S.